Intravesical therapy for urothelial carcinoma of the bladder

M. Manoharan

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory agent BCG and chemotherapeutic agents. We discuss the current guidelines and the role of these therapeutic agents in the context of higher grade Ta and T1 tumors.

Original languageEnglish (US)
Pages (from-to)252-261
Number of pages10
JournalIndian Journal of Urology
Issue number2
StatePublished - Apr 2011
Externally publishedYes


  • Bladder
  • cancer
  • chemotherapy
  • intravesical

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Intravesical therapy for urothelial carcinoma of the bladder'. Together they form a unique fingerprint.

Cite this